4019 |
Escalation and De-Escalation Strategy for DAPT: Rationale and Evidence |
Dominick J. Angiolillo |
Aug. 06. 20 |
4018 |
The DEFINE-FLOW Study: Combined CFR and FFR Lesion Assessment |
Nils Johnson |
Aug. 06. 20 |
4017 |
COVID-19 and Thrombotic or Thromboembolic Disease |
Dominick J. Angiolillo |
Aug. 06. 20 |
4016 |
COVID-19 and RAAS Inhibitors |
David Joel Cohen |
Aug. 06. 20 |
4015 |
Tailoring Antithrombotic Therapy in HBR Patient |
Dominick J. Angiolillo |
Apr. 27. 19 |
4014 |
Ultra-short DAPT: Are All Stents Equal? |
Soon Jun Hong |
Apr. 27. 19 |
4013 |
Identification of HBR Patients: The ARC-HBR Project |
Philip M. Urban |
Apr. 27. 19 |
4012 |
Complex PCI Cases with Recent IVUS Study |
Robert Thomas Gerber |
Apr. 27. 19 |
4011 |
iFR Guided PCI |
Hitoshi Matsuo |
Apr. 27. 19 |
4010 |
Smart PCI with Advanced Co-Registration System |
Bon-Kwon Koo |
Apr. 27. 19 |